Business Wire

Magnit Recognized as a Leader in Everest Group’s CWM/MSP PEAK Matrix for Second Consecutive Year

15.11.2022 17:00:00 EET | Business Wire | Press release

Share

Magnit™ (formerly PRO Unlimited), an integrated workforce management (IWM) platform provider, was named the “Market Impact Leader” in Everest Group’s annual Contingent Workforce Management (CWM)/Managed Service Provider (MSP) PEAK Matrix®. Everest Group’s 2022 CWM/MSP PEAK Matrix evaluated the performance of 24 service providers, offering insights to help enterprises make critical decisions about their market partners.

“In today’s market, companies need a strategic partner that understands the complexities of managing extended workforce programs and keeping up with organizational and market demands,” said Kevin Akeroyd, CEO of Magnit. “We work hard to be that partner for companies across industries, including numerous members of the Global 2000. Our continued recognition as an Everest Group CWM/MSP PEAK Matrix Leader is a testament to that work, our proven expertise, and the world-class data, talent intelligence, and modern software we offer.”

In addition to being named among the report’s leading providers, Magnit earned a “Star Performer” status in recognition of its progress over the past year. This is the second consecutive year in which the company has received this honor. Magnit rated highest among all providers for market impact, which speaks to the company’s significant market adoption, diverse portfolio, and exceptional value to clients as reflected in customer feedback.

“Magnit rapidly bolstered its contingent workforce offerings through both organic and inorganic investments and strengthened its positioning as a one-stop solution provider for clients’ contingent workforce needs,” said Krishna Charan, Practice Director, Everest Group. “Its investments in technology, enhanced market intelligence, analytics offerings, and expansion in the direct sourcing space have all contributed to its positioning as a Leader and a Star Performer on Everest Group’s CWM/MSP PEAK Matrix 2022.”

The company also ranked as a top performer in vision and capability, Everest Group’s other key metric for the PEAK Matrix. This category is intended to measure a company’s ability to deliver services to clients. The metric considers a provider’s vision and strategy; scope of services; innovation and investments; and delivery footprint. Magnit’s impressive performance in this regard reflects the company’s ongoing commitment to growth and improvement within the market.

Read the full report.

About Magnit™
Magnit™ is a global leader and pioneer in contingent workforce management. Our industry-leading Integrated Workforce Management (IWM) Platform is supported by 30+ years of innovation, modern software, proven expertise, and world-class data and intelligence. It enables companies to optimize talent and diversity goals while achieving operational and financial success. With Magnit, companies can adapt quickly to the evolution of work to grow their extended workforce with greater agility, transparency, and speed. magnitglobal.com

“Magnit” is a trademark or registered trademark of Magnit, LLC. Any trade, product, or service name referenced in this document using the name “Magnit” is a trademark and/or property of Magnit, LLC.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Andrew Petro, Account Manager
Matter Communications
MagnitPR@matternow.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

PPMI and Alipay+ Expand QR Ph for Cross-Border Commerce, Connecting Filipino Businesses with Global Consumers1.9.2026 10:25:00 EEST | Press release

The Philippine Payments Management, Inc. (PPMI) and Ant International's unified wallet gateway, Alipay+, have officially enabled Alipay+ on QR Ph, seamlessly connecting the nation's digital payments ecosystem with global commerce. This milestone is in alignment with and supports the Bangko Sentral ng Pilipinas' (BSP) digital payments transformation goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901759507/en/ (L-R) Danny Chung, General Manager of Alipay+ Global Growth Center, Ant International; Carmelita “Melit” Araneta, General Manager of Philippine Payments Management Inc.; Atty. Bridget Rose M. Mesina-Romero, Director, Payments Policy and Development Department, Bangko Sentral ng Philipinas According to the BSP’s 2025 Report on E-Payments Measurement, digital payments now account for 64.69% of retail transaction volume in the Philippines, while QR Ph transactions surged more than 13 times in 2025. By connecting t

Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds1.9.2026 10:00:00 EEST | Press release

Global sales of consumer technology and durable goods are forecast to reach $1.4 trillion in 2026, up 5.1% year over year, even as 56% of consumers say they have delayed a technology purchase because of price or while waiting for a discount, according to new research from NIQ (NYSE: NIQ), the Official Global Insights Partner of IFA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901758503/en/ The era of automatic tech & durables upgrades is over. Released ahead of IFA 2026, which kicks off in Berlin on Sept. 4, 2026, NIQ today released its annual “State of Tech & Durables” report. Consumer Tech Trends 2027: How to Win When Every Purchase Must Be Justified examines how years of economic volatility have transformed technology purchasing behavior and what manufacturers and retailers must do to remain competitive. Key findings include: Global T&D sales are forecast to reach $1.4 trillion in 2026, up 5.1% year over year 63% of

Searchlight Capital Partners Announces Investment in Aderian Group1.9.2026 10:00:00 EEST | Press release

Searchlight Capital Partners, L.P. ("Searchlight"), a leading global private investment firm, today announced an investment in Aderian Group ("Aderian" or the "Company"), a Nordic managed IT services provider serving more than 10,000 small and medium-sized enterprise ("SME") customers throughout Sweden and Norway. As part of the transaction, Aderian's management team will reinvest in the Company and remain meaningful shareholders alongside Searchlight, underscoring their continued commitment to Aderian's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901430715/en/ Aderian provides cloud, cybersecurity, AI and analytics, networking and modern workplace solutions. Since its founding in 2022, the Company has grown to approximately SEK 2.5 billion in revenue, with more than 850 employees and over 10,000 SME customers across Sweden and Norway. The Company has built deep, long-standing customer relationships b

FluoSphera Licenses Debiopharm’s AbYlink™ Technology for 3D Antibody Characterization while Leveraging Leica Microsystems Viventis Deep Imaging Capabilities1.9.2026 10:00:00 EEST | Press release

Debiopharm (Debiopharm Research & Manufacturing), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases and FluoSphera, a Swiss biotechnology company developing advanced in vitro platforms to improve the prediction of drug efficacy and safety, today announced a new license agreement for use of AbYlink™, Debiopharm’s proprietary antibody conjugation technology. The agreement enables FluoSphera to offer biotechnology and pharmaceutical companies an integrated workflow combining regio-selective antibody labeling, high-throughput testing in human-relevant three-dimensional models and quantitative imaging analysis. The new offering is designed to support the characterization of antibody-drug conjugates (ADCs), bispecific antibodies, therapeutic antibodies and other antibody-based modalities. Antibody candidates can be labeled using AbYlink™ and subsequently be evaluated with FluoSphera’s 3D testing pla

Enhertu ® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer1.9.2026 09:30:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from theDESTINY-Breast09 phase 3 trialpresented at the 2025 American Society of Clinical Oncology Annual Meeting and subsequently published in The New England Journal of Medicine. In DESTINY-Breast09, Enhertu in combination with pertuzumab reduced the risk of disease progression or death by 44% versus a taxan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye